In addition to the goal of using pluripotent stem cells in regenerative medicine, The Economist writes that drug companies are also interested in using them to test drugs. Pluripotent stem cells could be used to generate "pure cultures of cells," The Economist says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Eye on iPS

Just Look Within

Everything on a Chip

This Week in Cell

This Week in PLOS

This Week in Cell

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.